CIK 0001984086
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Septerna, Inc.
Sign in to watch- Ticker
- SEPN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 843891440
- Phone
- +1 650-338-3533
- Business address
- 250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO, CA, 94080
- 4 Derivatives Options or other derivatives
- 4 Planned sale SVP, Drug Discovery sold 15,000 shares at an average $35.51 ($532,582)
- 4 Planned sale Chief People Officer sold 6,250 shares at $35.08 ($219,224)
- 4 Planned sale Chief People Officer sold 5,935 shares at an average $28.93 ($171,682)
- 4 Planned sale Chief People Officer sold 11,798 shares at $30.06 ($354,656)
- 4 Planned sale President and COO sold 4,000 shares at an average $24.34 ($97,343)
- 4 Planned sale Chief People Officer sold 70,453 shares at an average $28.10 ($1,979,838)
- 4 Planned sale President and COO sold 4,000 shares at an average $28.97 ($115,860)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP, Drug Discovery sold 3,501 shares at $18.06 ($63,223)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 2 of 5 · 82 filings